Day: September 18, 2023

Air Filters Market Size to Surpass USD 25.69 billion by 2030 | Growing Imports to Propel Natural Stone Countertop Demand

According to Fortune Business Insights, the global Air Filters Market size is projected to grow from USD 14.68 billion in 2022 to USD 25.69 billion in 2030 at CAGR of 7.3% during forecast period Pune, india, Sept. 18, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global Air Filters Market size was valued at USD 14.68 billion in 2022. The market is anticipated to grow from USD 15.69 billion in 2023 to USD 25.69 billion by 2030, exhibiting a CAGR of 7.3% over the estimated period. The expansion is being driven by the rising formulation of customer-driven marketing strategies by key market players. Fortune Business Insights™ provides this information in its research report, titled “Air Filters Market, Forecast 2023-2030”. Industry Development: December 2021 – Camfil USA, Inc. announced the plan to...

Continue reading

77% of Employers Plan to Increase Investment in Virtual Health Care, says Teladoc Health’s 2023 Virtual Care Transformation Index

Findings from annual study also reinforce the value of whole-person care, equitable access and a balanced approach to GLP-1s & weight management for employers PURCHASE, NY, Sept. 18, 2023 (GLOBE NEWSWIRE) — In new research released today by Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, U.S. employers with 2,500 or more employees reported a 21% increase in the implementation of additional virtual care offerings over the past 18 months, with 77% stating they plan to increase their investment in virtual care over the next three years. The findings are part of the company’s second annual Virtual Care Transformation Index, a survey of more than 300 human resource decision makers that highlights the perception, adoption and advancement of whole-person virtual healthcare in benefits programs. “For employers,...

Continue reading

Smart Share Global Limited Announces Extension of Share Repurchase Program and Changes to Management Team

SHANGHAI, China, Sept. 18, 2023 (GLOBE NEWSWIRE) — Smart Share Global Limited (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced the extension of its share repurchase program and changes to management team. EXTENSION OF SHARE REPURCHASE PROGRAM The Company’s board of directors (the “Board”) authorized a further 12-month extension to its existing share repurchase program (the “Share Repurchase Program”) through September 27, 2024. The Share Repurchase Program was originally approved by the Board on September 28, 2021, under which the Company may repurchase up to US$50.0 million of its shares (including in the form of ADSs) through September 27, 2022. On September 28, 2022, the Company announced that the Share Repurchase Program was extended through September 27,...

Continue reading

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

– Topline results from this study are expected in early Q1 2024 – Celltrion has a right of first negotiation for RT-111 following positive Phase 1 results SAN JOSE, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the initiation of a Phase 1 clinical trial to evaluate the safety and tolerability of RT-111, an orally administered RaniPill®GO capsule containing an ustekinumab biosimilar, CT-P43. Topline results from this study are expected early in the first quarter of 2024. Ustekinumab is a human IgG1қ monoclonal antibody that binds with specificity to the p40 protein subunit used by both the interleukin-12 and interleukin-23 (IL-12 and...

Continue reading

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, 2023 in Boston, Massachusetts. The details of NuCana’s presentations at the meeting are as follows: Abstract title: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)Poster number: B048Session: Poster Session BSession date and time: Friday, October 13 from 12:30pm-4:00pmPresenting Author: Dr. Khurum Khan Abstract title: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic...

Continue reading

Katapult to Participate in Sidoti Small-Cap Conference

PLANO, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce focused financial technology company, announced that Orlando Zayas, CEO, and Nancy Walsh, CFO, will participate in the Sidoti Small-Cap Conference on Thursday, September 21, 2023. Orlando Zayas and Nancy Walsh will host a presentation and Q&A session at 1:00 PM ET. A live audio webcast and replay will be available on the Company’s Investor Relations website at https://ir.katapultholdings.com/. About KatapultKatapult is a technology driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchasing of everyday durable goods for underserved U.S. non-prime consumers. Through our point-of-sale (POS) integrations and innovative, mobile app featuring...

Continue reading

Skyward Specialty Expands Healthcare Appetite with Rebrand and Adds Individual Provider Coverage

HOUSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”) a leader in the specialty property and casualty (P&C) market, announced it is expanding its coverages in the healthcare sector adding a new solution catering to the distinct needs of E&S individual providers, including physicians. The healthcare landscape continues to present new challenges and opportunities for healthcare professionals, especially for individual providers and physicians. The demand for this type of coverage has outpaced the insurance market’s capacity and capabilities, resulting in a growing need for bespoke solutions for healthcare professionals. “We understand the critical role that individual providers and physicians play in the healthcare...

Continue reading

NewLake Capital Partners Maintains Third Quarter 2023 Common Stock Dividend of $0.39 per Share

NEW CANAAN, Conn., Sept. 18, 2023 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that its board of directors has declared a third quarter 2023 cash dividend of $0.39 per share of common stock. The dividend is equivalent to an annualized dividend of $1.56 per common share. The dividend is payable on October 13, 2023, to stockholders of record at the close of business on September 29, 2023. About NewLake Capital Partners, Inc. NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects. NewLake owns...

Continue reading

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available  Evaxion’s proprietary AI-platforms EDEN™ and RAVEN™ will be utilized for rapid design of a completely novel vaccine candidate capable of eliciting both a humoral (antibody) and cellular immune response to the pathogen Collaborative and co-funded project between two companies with strong scientific alignment and complementary skill sets and capabilities This collaboration underlines Evaxion’s strategic focus of harnessing the power of AI to identify new targets significantly more efficiently than traditional methods COPENHAGEN, Denmark, Sept. 18, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development...

Continue reading

The Francis Group at LPL Launches in California by Joining LPL Strategic Wealth Services

CHARLOTTE, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Burke Francis and Christopher Francis, who have more than 80 years of combined experience, have joined LPL Financial to launch an exclusive family-focused office and independent practice, The Francis Group at LPL. They chose to affiliate with LPL’s supported independence model, LPL Strategic Wealth Services. The Francis Group reported having served approximately $1.2 billion in advisory, brokerage and retirement plan assets*. They join from Morgan Stanley. Since 1966, Burke Francis steadily built the Los Angeles area practice from the ground up by specializing in asset management for high-net-worth individuals. His son, Chris, joined the business in 1998, after working in real estate development and numerous venture backed companies. Burke...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.